Nuskin Enterprises Inc: (NYSE: NUS)

$60.86

-1.27 (-2.04%)

Volume 1,531,029

May 22 04:03 PM ET

Zacks Rank: 1-Strong Buy

#1
 
 
 
 

Full Company Report

Get Full Company Report for:

Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes premium-quality, innovative personal care and nutritional products. The company also markets and distributes technology, Internet and telecommunications services and products. The company distributes its products exclusively through a network marketing system. They currently have a network of active distributors located throughout its markets that purchase products for resale to consumers and for personal consumption.

General Information

NU SKIN ENTERP
75 WEST CENTER ST ATTN: D. MATTHEW DORNY
PROVO, UT 84601
Phone: 801-345-6100
Fax: 801-345-5999
Web: http://www.nuskinenterprises.com
Email: spond@nuskin.com

Industry COSMETICS&TLTRS
Sector Consumer Staples
Fiscal Year End December
Last Reported Quarter 03/31/2013
Next EPS Date 07/25/2013

Price and Volume Information

Zacks Rank
Yesterday's Close 62.13
52 Week High 63.35
52 Week Low 32.36
Beta 1.27
20 Day Moving Average 973,593.63
Target Price Consensus 66.00

% Price Change

4 Week 22.44
12 Week 59.26
YTD 69.50

Share Information

Shares Outstanding (millions) 58.41
Market Capitalization (millions) 3,646.66
Short Ratio 8.84
Last Split Date NA

NUS

% Price Change Relative to S&P 500

4 Week 15.81
12 Week 42.83
YTD 41.35

Dividend Information

Dividend Yield 1.92%
Annual Dividend $1.20
Payout Ratio 0.33
Change in Payout Ratio 0.02
Last Dividend Payout / Amount 02/20/2013 / $0.30

EPS Information

Current Quarter EPS Consensus Estimate 0.96
Current Year EPS Consensus Estimate 4.31
Estimated Long-Term EPS Growth Rate 12.40
Next EPS Report Date 07/25/2013

Consensus Recommendations

Current (1=Strong Buy, 5=Strong Sell) 1.25
30 Days Ago 1.00
60 Days Ago 1.00
90 Days Ago 1.00

Fundamental Ratios

P/E

Current FY Estimate 14.49
Trailing 12 Months 16.97
PEG Ratio 1.17

Price Ratios

Price/Book 5.90
Price/Cash Flow 14.37
Price / Sales 1.62

Current Ratio

03-31-13 1.72
12-31-12 1.87
09-30-12 2.01

Net Margin

03-31-13 10.10
12-31-12 10.22
09-30-12 10.20

Inventory Turnover

03-31-13 2.69
12-31-12 2.73
09-30-12 2.74

EPS Growth

vs. Previous Year 21.62%
vs. Previous Quarter -7.22%
   

ROE

03-31-13 39.24
12-31-12 38.06
09-30-12 36.65

Quick Ratio

03-31-13 1.31
12-31-12 1.45
09-30-12 1.56

Pre-Tax Margin

03-31-13 15.62
12-31-12 15.91
09-30-12 15.86

Debt-to-Equity

03-31-13 0.23
12-31-12 0.26
09-30-12 0.33

Sales Growth

vs. Previous Year 19.07%
vs. Previous Quarter -6.49%
   

ROA

03-31-13 19.79
12-31-12 20.00
09-30-12 19.85

Operating Margin

03-31-13 10.10
12-31-12 10.22
09-30-12 10.20

Book Value

03-31-13 10.57
12-31-12 10.06
09-30-12 9.19

Debt to Capital

03-31-13 18.37
12-31-12 20.78
09-30-12 24.93

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.